Navigation Links
AutoGenomics, Inc. Files Registration Statement for Initial Public Offering
Date:7/25/2008

CARLSBAD, Calif., July 25 /PRNewswire/ -- AutoGenomics, Inc. today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to the proposed initial public offering of shares of its common stock. The number of shares of common stock to be offered, all of which are expected to be offered by AutoGenomics, Inc., and the price range for the offering, have not yet been determined.

J.P. Morgan Securities Inc. is acting as sole book-running manager of the offering, and Deutsche Bank Securities Inc. is acting as co-lead manager. Pacific Growth Equities, LLC and Robert W. Baird & Co. Incorporated are acting as co-managers.

The offering will be made only by means of a prospectus. When available, copies of the preliminary prospectus relating to this offering may be obtained by contacting: J.P. Morgan Securities Inc., 4 Chase Metrotech Center, CS Level, Brooklyn, NY 11245 Attention: Chase Distribution & Support Service Northeast Statement Processing.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission, but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to their registration or qualification under the securities laws of any such state.

About AutoGenomics

AutoGenomics Inc., a privately held company based in Carlsbad, CA, has developed the first automated, microarray based multiplexing diagnostic platform that can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious disease, cancer and pharmacogenetics. With the discovery of genes and their link to various disease states the platform has the versatility to revolutionize the way patients are diagnosed, monitored and managed leading to the era of personalized medicine.


'/>"/>
SOURCE AutoGenomics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Donahey Law Firm Files E. Coli Product Liability Lawsuit Against Kroger Company in Franklin County Court
2. The Quantum Group Files TPA Application
3. Noesis Health Introduces AdvancedSMAT for Better Management of Cloverleaf Message Files
4. MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada
5. VNUS Medical Technologies, Inc. Files Patent Infringement Lawsuits Against Biolitec, Dornier and CoolTouch
6. Sangui BioTech Files Three 2007 Quarterly Reports, Sales Increased, Losses Continue
7. IPC The Hospitalist Company, Inc. Files Registration Statement for Proposed Offering
8. Synovics Pharmaceuticals Files Its Second Quarter, 2008 Form 10Q with the SEC
9. Pharmacyclics Files Schedule 14D-9 Statement with Securities and Exchange Commission
10. Castle Connollys Long Islands Top Doctors Published in Newsday Generates More Than 1.1 Million Views of Top Doctors Profiles in Single Day
11. The Quantum Group Files Four Additional Patents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 2017 , ... Hamlin Dental Group, multi-location dental office in North Hollywood ... lasers are safe and effective options, and can be used alone or in conjunction ... quality of care. , Dr. Hamid Reza of Hamlin Dental Group offers other treatments ...
(Date:3/29/2017)... NJ (PRWEB) , ... March 29, 2017 , ... ... School of Gastrointestinal Oncology™ (SOGO™), a specialized continuing medical education conference for clinicians ... 29 at Intercontinental Time Square, New York. , The program will be ...
(Date:3/29/2017)... ... 29, 2017 , ... AvePoint , the Microsoft Cloud expert, is pleased ... Virginia, located at the Riverfront Plaza, 901 East Byrd Street. AvePoint is celebrating with ... S. Northam and Mayor of Richmond Levar M. Stoney. , Founded in 2001, AvePoint ...
(Date:3/28/2017)... ... March 28, 2017 , ... A recent Bellwether ... teacher quality, the field must first improve teacher preparation program design. It then ... next” and that decades of input- and outcome-based research has failed to improve ...
(Date:3/28/2017)... ... March 28, 2017 , ... For many women, getting birth control isn’t as easy as it ... either don’t have access to a health care facility or a pharmacy within 60 minutes ... the United States or for many who are faced with health or personal issues that ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 29, 2017 Research and Markets has announced ... Software Market Outlook: 2016-2022" report to their offering. ... The global patient safety ... of delivery, end-user, and geography. Patient safety has ... globe. The field has developed significantly in the last decade and ...
(Date:3/28/2017)... "Chemotherapy Induced Neutropenia (CIN) – Market Insights, Epidemiology and Market Forecast-2023" ... of the Chemotherapy Induced Neutropenia for the seven major markets i.e., ... ( France , Germany , ... Japan , as well as rest of ... The Report covers the therapeutics market revenue, treatment practice ...
(Date:3/28/2017)...  Medeon Biodesign, Inc., a Taiwan ... announce that the Company led and successfully closed ... a San Jose, CA ... extremity applications.  The orthopedic extremity ... to procedure volume growth, lifestyle influences and favorable ...
Breaking Medicine Technology: